Skip to main content
All Case Studies01 · Flagship Engagement

Chronus Health

Whole-blood electrical detection platform — CBC, CMP, and electrolytes from a single cartridge. No sample prep. No optical detection.

Co-FoundersCBC · CMP · Electrolytes$28M+ RaisedCLIA Waiver Candidate
The Platform

Whole-Blood Electrical Detection

The Challenge

Build a CLIA-waived point-of-care device for CBC and CMP testing from undiluted whole blood — no sample prep, no optical detection, and a manufacturing path to sub-dollar cartridge COGS.

Our Role

Co-founders and technical leads across chemistry, sensor design, electronics, and system integration — from feasibility through IRB-approved clinical studies and FDA pre-submission.

How It Works

  • 100% electrical detection — no optical components, no sample prep
  • Multiplexed: CBC, CMP, electrolytes, and small molecules from a single cartridge
  • Proprietary aptamer sequences across 13 analyte targets
  • Custom 4-channel lock-in amplifier built in-house at <$2k (vs. $40k+ commercial)
  • Ionophore-doped membranes for direct potentiometric electrolyte read from whole blood
Chronus Health whole-blood CBC reader device with tablet interface

Chronus Health whole-blood POC reader

Cell Counting

Complete Blood Count (CBC)

Whole-cell impedance spectroscopy measures red blood cells, white blood cells, and platelets directly from undiluted whole blood. No lysing agents. No dilution. No optical path.

The sensor is a microfabricated, microfluidic device built on a glass wafer — featuring 4 parallel measurement paths for simultaneous multi-analyte detection. The glass substrate enables precise electrode geometries and low non-specific binding critical for whole-blood performance.

The single-use cartridge integrates buffer, mixing chambers, and waste reservoirs alongside the sensor on a single platform — no external reagents, no benchtop preparation. The only step required from the end user is a simple whole-blood dilution before loading.

Validated against a commercial hematology analyzer across 25 volunteers in an IRB-approved study.

25 volunteers · IRB-approved · vs. commercial hematology analyzer

CBC — Correlation (r)

Analyter
Red blood cells0.96
Platelets0.92
Total white blood cells0.92
Neutrophils0.93
Lymphocytes0.89
Chronus Health CBC cartridge diagram showing blood inlet, buffer reservoirs, mixing reservoirs, waste reservoirs, and sensor

Single-use CBC cartridge — blood inlet, buffer & mixing reservoirs, sensor array

CBC electrochemical sensor strip shown next to a quarter for scale

CBC electrochemical sensor strip — shown to scale

Protein Panel

Comprehensive Metabolic Panel (CMP)

Liver enzymes and proteins are detected using aptamer-based amperometric electrochemical measurement. Each analyte has a proprietary aptamer sequence selected, screened, and validated in-house — no antibodies, no labels, no reagents consumed per test.

The platform uses proprietary aptamer sequences across 13 analyte targets, representing a core IP asset of the Chronus Health platform.

Detection method

Aptamer-based amperometric detection — label-free, reagentless binding measurement directly from whole blood with no sample preparation required.

25 volunteers · IRB-approved · vs. commercial chemistry analyzer

CMP — Correlation (r)

Analyter
ALT0.91
AST0.96
ALP0.96
Albumin0.96
Total protein0.92
Ion Detection

Electrolytes & Small Molecules

Electrolytes and small molecules are measured potentiometrically using ionophore-doped polymer membranes — the same principle as ISE-based lab analyzers, miniaturized into a single-use disposable cartridge.

No enzymatic reagents. No reference electrode consumables. Direct read from undiluted capillary or venous whole blood in clinical ranges.

Detection method

Potentiometric ion-selective electrodes (ISE) with ionophore-doped PVC membranes — direct ion activity measurement in whole blood. r² > 0.99 across sodium, potassium, and creatinine.

25 volunteers · IRB-approved · vs. commercial chemistry analyzer

Electrolytes — Correlation (r²)

Analyte
Sodium0.994
Potassium0.993
Glucose0.950
Creatinine0.991
BUN0.990
Total CO₂0.950

Key Engineering Achievements

<$2k

Custom 4-channel lock-in amplifier

vs. $40k+ commercial equivalent

13

Analyte targets

Proprietary aptamer sequences

$0.80

Cartridge COGS target

At 25M units/yr via design + automation

CLIA

Waiver candidate

FDA pre-submission filed

Twenty Seven Labs BSL-2 chemistry lab — fume hood and wet chemistry bench, Hayward CA

Twenty Seven Labs R&D facility, Hayward CA — BSL-2 equipped chemistry lab

Outcomes

$28M+
Raised
Pre-Sub Filed
FDA pathway initiated
CLIA Waiver
Candidate classification
Back to all case studies

Building Something in Diagnostics?

Let's talk through your project. Initial calls are 30 minutes and completely free.